Lexpos News

MHRA Class 3 Medicines Recall: Ibuprofen 200mg Tablets, Ibucalm 200mg tablets (Aspar Pharmaceuticals Ltd) Drug Alert Number: EL(26)A/07 Date issued: 04 February 2026 Aspar Pharmaceuticals Ltd is recalling specific batches distributed in Aspar, Almus and Numark livery. The batches are being recalled as a precautionary measure following findings of foil perforations in some blisters. DMRC reference [...]

The post MHRA Class 3 Medicines Recall: Ibuprofen 200mg Tablets, Ibucalm 200mg tablets (Aspar Pharmaceuticals Ltd) appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (04/02/2026) confirmed the following final list of price concessions for January 2026. Drug Pack size Price concession Ascorbic acid 200mg tablets 28 £47.05 Captopril 12.5mg tablets 56 £27.95 Captopril 25mg tablets 56 £25.95 Captopril 50mg tablets 56 £26.95 Carvedilol 6.25mg tablets 28 £1.20 Chlordiazepoxide 10mg capsules [...]

The post January 2026 Price Concessions Final Update appeared first on Community Pharmacy England.

A new report from the House of Lords Public Services Committee calls for better data sharing and a more proactive Government approach to managing medicines shortages, describing medicines supply as “a national security issue”. Published today (4th February), the report on the Lords Committee’s inquiry into medicines security concludes that the UK is heavily dependent [...]

The post Lords warn medicine shortages now a national security risk appeared first on Community Pharmacy England.

Community Pharmacy England is releasing guidance ahead of a webinar to explain Category H, the new Drug Tariff category, to pharmacy owners. We have published a comprehensive guide to the new Category H, explaining how entry to and price-setting arrangements for Category H will operate, as well as the background to these changes. Briefing: Category H FAQs Category H webpage List of products moving [...]

The post Category H: guidance and support for pharmacy owners appeared first on Community Pharmacy England.

MHRA Class 2 Medicines Recall: Baclofen 10mg/5ml Oral Solution (Syri Limited, T/A SyriMed) Drug alert number: EL(26)A/06 Date issued: 3 February 2026 Syri Limited, T/A SyriMed is recalling batches of product as a precautionary measure due to crystallisation observed over time in the oral solution. DMRC reference number: DMRC-38317957 Company name:Syri Limited, T/A SyriMed Medicine Details [...]

The post MHRA Class 2 Medicines Recall: Baclofen 10mg/5ml Oral Solution (Syri Limited, T/A SyriMed) appeared first on Community Pharmacy England.